Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Technology Assessment, Biomedical"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 653
Tytuł:
Exploring the landscape of health technology assessment in Iran: perspectives from stakeholders on needs, demand and supply.
Autorzy:
Aryankhesal A; School of Health Sciences, Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK.
Behzadifar M; Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Bakhtiari A; Health Equity Research Center (HERC), Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Shahabi S; Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Azari S; Hospital Management Research Center, Health Management Research Institute, University of Medical Sciences, Tehran, Iran.
Darvishi Teli B; Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Rezapour A; Health Management and Economics Research Center, Health Management Research Institute, Iran, University of Medical Sciences, Tehran, Iran.
Ehsanzadeh SJ; English Language Department, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Behzadifar M; Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran. .
Pokaż więcej
Źródło:
Health research policy and systems [Health Res Policy Syst] 2024 Jan 15; Vol. 22 (1), pp. 11. Date of Electronic Publication: 2024 Jan 15.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Delivery of Health Care*
Technology Assessment, Biomedical*
Humans ; Male ; Iran ; Policy Making ; Resource Allocation ; Female
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Opportunities to improve the adoption of health-related quality of life evidence as part of the French Health Technology Assessment process.
Autorzy:
Larose H; The Boston Consulting Group, 80 Charlotte Street, London, W1T 4QS, United Kingdom. .
Lee M; The Boston Consulting Group, 80 Charlotte Street, London, W1T 4QS, United Kingdom.
Grueger J; University of Washington, Seattle, WA, United States of America.; The Boston Consulting Group, Zurich, Switzerland.
Anota A; Department of Clinical Research and Innovation and Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France.
Naïditch N; French Federation of Diabetics, Paris, France.
Falissard B; CESP, Université Paris-Saclay, APHP, Villejuif, France.
Di Palma M; Gustave Roussy Cancer Center, Paris-Saclay University, Villejuif, France.
Chassany O; Health Economics Clinical Trial Unit (URC-ECO), Hôpital Hotel-Dieu, AP-HP, Paris, France.; Patient-Reported Outcomes Research Unit (PROQOL), Université Paris Cité, Paris, France.
Khalfallah-Neelz L; AstraZeneca, Paris, France.
Palazuelos-Muñoz S; AstraZeneca, Paris, France.
Tetafort A; AstraZeneca, Paris, France.
Pokaż więcej
Źródło:
Health research policy and systems [Health Res Policy Syst] 2023 Dec 19; Vol. 21 (1), pp. 137. Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:
Systematic Review; Journal Article
MeSH Terms:
Technology Assessment, Biomedical*/methods
Quality of Life*
Humans ; France ; Germany ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Research gaps identified in Iran's health technology assessment reports.
Autorzy:
Mohtasham F; Knowledge Utilization Research Centre (KURC), Tehran University of Medical Sciences, Kargar St., Keshavarz Blvd, P.O. Box 1417993357, Tehran, Iran. .
Yazdizadeh B; Knowledge Utilization Research Centre (KURC), Tehran University of Medical Sciences, Kargar St., Keshavarz Blvd, P.O. Box 1417993357, Tehran, Iran.
Mobinizadeh M; National Institute for Health Research, Tehran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
Health research policy and systems [Health Res Policy Syst] 2023 Dec 11; Vol. 21 (1), pp. 132. Date of Electronic Publication: 2023 Dec 11.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Technology Assessment, Biomedical*
Evidence Gaps*
Humans ; Iran ; Research Report ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
survextrap: a package for flexible and transparent survival extrapolation.
Autorzy:
Jackson CH; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK. .
Pokaż więcej
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2023 Nov 29; Vol. 23 (1), pp. 282. Date of Electronic Publication: 2023 Nov 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Seizures*
Technology Assessment, Biomedical*
Humans ; Survival Analysis ; Bayes Theorem
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective.
Autorzy:
Husereau D; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON K1G 5Z3, Canada.
Bombard Y; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON M5T 3M6, Canada.; Genomics Health Services Research Program, Li Ka Shing Knowledge Institute, Michael's Hospital, Unity Health Toronto, Toronto, ON M5B 1T8, Canada.
Stockley T; Division of Clinical Laboratory Genetics, Laboratory Medicine Program, University Health Network, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada.
Carter M; Department of Pathology and Laboratory Medicine, Nova Scotia Health (Central Zone), Halifax, NS B3H 1V8, Canada.
Davey S; Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON K7L 3N6, Canada.; Division of Cancer Biology and Genetics, Queen's University Cancer Research Institute, Queen's University, Kingston, ON K7L 3N6, Canada.; Departments of Oncology and Biomedical and Molecular Sciences, Queen's University Cancer Research Institute, Queen's University, Kingston, ON K7L 2V7, Canada.
Lemaire D; Ontario Institute for Cancer Research, 661 University Ave, Toronto, ON M5G 0A3, Canada.
Nohr E; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.; Alberta Precision Laboratories, Foothills Medical Center, 1403 29 St NW, Calgary, AB T2N 2T9, Canada.
Park P; Department of Pathology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1R9, Canada.
Spatz A; Division of Pathology, McGill University Health Center, 1001 Decarie Blvd., Montreal, QC H4A 3J, Canada.; OPTILAB-MUHC & Department of Laboratory Medicine, 1001 Decarie Blvd., Montreal, QC H4A 3J, Canada.; Research Molecular Pathology Center, Lady Davis Institute, 3755 Côte Ste-Catherine Road, Montreal, QC H3T 1E2, Canada.
Williams C; Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON K7L 3N6, Canada.; Ontario Institute for Cancer Research, 661 University Ave, Toronto, ON M5G 0A3, Canada.
Pollett A; Pathology & Laboratory Medicine, Sinai Health System, Toronto, ON M5G 1X5, Canada.; Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Lo B; The Ottawa General Hospital, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada.
Yip S; Department of Pathology & Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada.
El Hallani S; Alberta Precision Laboratory, Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2R7, Canada.
Feilotter H; Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON K7L 3N6, Canada.; Ontario Institute for Cancer Research, 661 University Ave, Toronto, ON M5G 0A3, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Oct 31; Vol. 30 (11), pp. 9660-9669. Date of Electronic Publication: 2023 Oct 31.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Genomic Medicine*
Technology Assessment, Biomedical*
Humans ; Canada ; Medical Oncology ; Genomics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Utilization of innovative medical technologies in German inpatient care: does evidence matter?
Autorzy:
Eckhardt H; Department of Health Care Management, Technische Universität Berlin, Straße Des 17. Juni 135, 10623, Berlin, Germany. .
Felgner S; Department of Health Care Management, Technische Universität Berlin, Straße Des 17. Juni 135, 10623, Berlin, Germany.; Berlin Centre for Health Economics Research (BerlinHECOR), Technische Universität Berlin, Straße Des 17. Juni 135, 10623, Berlin, Germany.
Dreger M; Department of Health Care Management, Technische Universität Berlin, Straße Des 17. Juni 135, 10623, Berlin, Germany.; Berlin Centre for Health Economics Research (BerlinHECOR), Technische Universität Berlin, Straße Des 17. Juni 135, 10623, Berlin, Germany.
Fuchs S; Department of Health Care Management, Technische Universität Berlin, Straße Des 17. Juni 135, 10623, Berlin, Germany.
Ermann H; Department of Health Care Management, Technische Universität Berlin, Straße Des 17. Juni 135, 10623, Berlin, Germany.
Rödiger H; Department of Health Care Management, Technische Universität Berlin, Straße Des 17. Juni 135, 10623, Berlin, Germany.
Rombey T; Department of Health Care Management, Technische Universität Berlin, Straße Des 17. Juni 135, 10623, Berlin, Germany.
Busse R; Department of Health Care Management, Technische Universität Berlin, Straße Des 17. Juni 135, 10623, Berlin, Germany.; Berlin Centre for Health Economics Research (BerlinHECOR), Technische Universität Berlin, Straße Des 17. Juni 135, 10623, Berlin, Germany.
Henschke C; Department of Health Care Management, Technische Universität Berlin, Straße Des 17. Juni 135, 10623, Berlin, Germany.; Berlin Centre for Health Economics Research (BerlinHECOR), Technische Universität Berlin, Straße Des 17. Juni 135, 10623, Berlin, Germany.
Panteli D; Department of Health Care Management, Technische Universität Berlin, Straße Des 17. Juni 135, 10623, Berlin, Germany.
Pokaż więcej
Źródło:
Health research policy and systems [Health Res Policy Syst] 2023 Oct 02; Vol. 21 (1), pp. 100. Date of Electronic Publication: 2023 Oct 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Inpatients*
Technology Assessment, Biomedical*
Humans ; Databases, Factual ; Germany
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Gaps in the evidence underpinning high-risk medical devices in Europe at market entry, and potential solutions.
Autorzy:
Hulstaert F; Administrative Centre Botanique, Belgian Health Care Knowledge Centre (KCE), Doorbuilding (10th floor), Boulevard du Jardin Botanique 55, Brussels, B-1000, Belgium. .
Pouppez C; Administrative Centre Botanique, Belgian Health Care Knowledge Centre (KCE), Doorbuilding (10th floor), Boulevard du Jardin Botanique 55, Brussels, B-1000, Belgium.
Primus-de Jong C; Administrative Centre Botanique, Belgian Health Care Knowledge Centre (KCE), Doorbuilding (10th floor), Boulevard du Jardin Botanique 55, Brussels, B-1000, Belgium.
Harkin K; Centre for Health Policy and Management, Trinity College Dublin, 3-4 Foster Place, Room 0.18, Dublin, Ireland.
Neyt M; Administrative Centre Botanique, Belgian Health Care Knowledge Centre (KCE), Doorbuilding (10th floor), Boulevard du Jardin Botanique 55, Brussels, B-1000, Belgium.
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2023 Jul 25; Vol. 18 (1), pp. 212. Date of Electronic Publication: 2023 Jul 25.
Typ publikacji:
Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Technology Assessment, Biomedical*
Research Design*
Humans ; Europe ; Risk Assessment ; Treatment Outcome ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development and validation of Medical Device Key Evidence Tool ('MeDKET'): An evidence-based framework to explain success in selected European and US companies.
Autorzy:
Manetti S; Department of Management Engineering, Politecnico di Milano, Milano, Italy.
Lettieri E; Department of Management Engineering, Politecnico di Milano, Milano, Italy.
Ni MZ; London In-Vitro Diagnostics (LIVD) Cooperative, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Jul 13; Vol. 18 (7), pp. e0288126. Date of Electronic Publication: 2023 Jul 13 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Industry*
Technology Assessment, Biomedical*
Retrospective Studies ; Consensus ; Checklist
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Factors influencing institutionalization of health technology assessment in Kenya.
Autorzy:
Mbau R; Department of Global Health and Development, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. .; Health Economics Research Unit, KEMRI Wellcome Trust Research Programme, 197 Lenana Place, P.O. BOX 43640-00100, Nairobi, Kenya. .
Vassall A; Department of Global Health and Development, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Gilson L; Department of Global Health and Development, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.; Health Policy and Systems Division, School of Public Health and Family Medicine, University of Cape Town, Anzio Road 7925, Cape Town, South Africa.
Barasa E; Health Economics Research Unit, KEMRI Wellcome Trust Research Programme, 197 Lenana Place, P.O. BOX 43640-00100, Nairobi, Kenya.; Centre for Global Health and Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford, OX3 7LG, UK.; Institute of Healthcare Management, Strathmore University, Karen Ole Sangale Road, P.O. BOX 59857-00200, Nairobi, Kenya.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2023 Jun 22; Vol. 23 (1), pp. 681. Date of Electronic Publication: 2023 Jun 22.
Typ publikacji:
Journal Article
MeSH Terms:
Technology Assessment, Biomedical*
Delivery of Health Care*
Humans ; Kenya ; Health Policy ; Resource Allocation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Which value aspects are relevant for the evaluation of medical devices? Exploring stakeholders' views through a Web-Delphi process.
Autorzy:
Freitas L; CEG-IST, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001, Lisbon, Portugal. .
Vieira ACL; CEG-IST, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001, Lisbon, Portugal.
Oliveira MD; CEG-IST, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001, Lisbon, Portugal.; iBB- Institute for Bioengineering and Biosciences and i4HB- Associate Laboratory Institute for Health and Bioeconomy, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1, Lisbon, 1049-001, Portugal.
Monteiro H; Infarmed, I. P., Lisbon, Portugal.
Bana E Costa CA; CEG-IST, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001, Lisbon, Portugal.; LSE Health-Medical Technology Research Group (MTRG), London School of Economics, Houghton St, London, WC2A 2AE, UK.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2023 Jun 08; Vol. 23 (1), pp. 593. Date of Electronic Publication: 2023 Jun 08.
Typ publikacji:
Journal Article
MeSH Terms:
Equipment and Supplies*/standards
Technology Assessment, Biomedical*/standards
Delphi Technique
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Involving people with a lived experience when developing a proposal for Health Technology Assessment research of nonsurgical treatments for pelvic organ prolapse: Process and reflections.
Autorzy:
Johnson EE; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Lally J; Research Design Service North East and North Cumbria, Newcastle upon Tyne, UK.
Farnworth A; Research Design Service North East and North Cumbria, Newcastle upon Tyne, UK.
Pearson F; NIHR Innovation Observatory, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Pokaż więcej
Źródło:
Health expectations : an international journal of public participation in health care and health policy [Health Expect] 2023 Jun; Vol. 26 (3), pp. 1127-1136. Date of Electronic Publication: 2023 Feb 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Technology Assessment, Biomedical*
Pelvic Organ Prolapse*/therapy
Humans ; Female ; Patient Participation ; Cost-Benefit Analysis ; Research Personnel
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?
Autorzy:
Drummond M; Centre for Health Economics, University of York, York, UK. .; CERGAS, SDA Bocconi School of Management, Milan, Italy. .
Ciani O; CERGAS, SDA Bocconi School of Management, Milan, Italy.
Fornaro G; CERGAS, SDA Bocconi School of Management, Milan, Italy.
Jommi C; CERGAS, SDA Bocconi School of Management, Milan, Italy.
Dietrich ES; University of Bonn Pharmaceutical Institute, Bonn, Germany.
Espin J; Andalusian School of Public Health, Andalusia, Spain.
Mossman J; Patient Representative and Visiting Senior Research Associate in the Medical Technology Research Group, LSE Health, London School of Economics, London, UK.
de Pouvourville G; ESSEC, Paris, France.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2023 May 13; Vol. 23 (1), pp. 484. Date of Electronic Publication: 2023 May 13.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Technology Assessment, Biomedical*
Humans ; Uncertainty
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Synergy between health technology assessments and clinical guidelines for multiple sclerosis.
Autorzy:
Hogervorst MA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.; National Health Care Institute (ZIN), Diemen, The Netherlands.
Vreman RA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.; National Health Care Institute (ZIN), Diemen, The Netherlands.
Zawada A; Department of Pharmacoeconomics, Medical University of Warsaw, Warsaw, Poland.
Zielińska M; Department of Pharmacoeconomics, Medical University of Warsaw, Warsaw, Poland.
Dawoud DM; National Institute for Health and Care Excellence (NICE), London, UK.; Faculty of Pharmacy, Clinical Pharmacy Department, Cairo University, Cairo, Egypt.
de Jong BA; Department of Neurology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, MS Center Amsterdam, Amsterdam, The Netherlands.
Mantel-Teeuwisse AK; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.
Goettsch WG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.; National Health Care Institute (ZIN), Diemen, The Netherlands.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2023 May; Vol. 16 (5), pp. 835-849. Date of Electronic Publication: 2023 Mar 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Technology Assessment, Biomedical*
Multiple Sclerosis*/diagnosis
Multiple Sclerosis*/drug therapy
Humans ; Cost-Benefit Analysis ; European Union ; Netherlands
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A qualitative study on the feasibility and acceptability of institutionalizing health technology assessment in Malawi.
Autorzy:
Mfutso-Bengo J; Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi. .; Centre of Bioethics in Eastern and Southern Africa, Blantyre, Malawi. .
Jeremiah F; Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.
Kasende-Chinguwo F; Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.
Ng'ambi W; Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.; Centre of Excellence in Ethics and Governance, Blantyre, Malawi.
Nkungula N; Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.
Kazanga-Chiumia I; Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.
Juma M; Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.
Chawani M; Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.; Malawi-Liverpool-Wellcome Programme, Blantyre, Malawi.
Chinkhumba J; Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.
Twea P; Ministry of Health, Malawi Government, Lilongwe, Malawi.
Chirwa E; Ministry of Health, Malawi Government, Lilongwe, Malawi.
Langwe K; Ministry of Health, Malawi Government, Lilongwe, Malawi.
Manthalu G; Ministry of Health, Malawi Government, Lilongwe, Malawi.
Ngwira LG; Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.
Nkhoma D; Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.
Colbourn T; University College London, London, United Kingdom.
Revill P; Centre for Health Economics, University of York, York, UK.
Sculpher M; Centre for Health Economics, University of York, York, UK.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2023 Apr 11; Vol. 23 (1), pp. 353. Date of Electronic Publication: 2023 Apr 11.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Technology Assessment, Biomedical*/methods
Humans ; Malawi ; Feasibility Studies ; Qualitative Research ; Focus Groups
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Access to novel drugs and therapeutics for children and youth: Eliciting citizens' values to inform public funding decisions.
Autorzy:
Gauvreau CL; Child Health Evaluative Sciences Program, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
Wight L; Child Health Evaluative Sciences Program, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
Subasri M; Child Health Evaluative Sciences Program, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
Palmer A; Ac2orn: Advocacy for Canadian Childhood Oncology Research, Toronto, Ontario, Canada.
Hayeems R; Child Health Evaluative Sciences Program, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.; Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Croker A; Centre for Policy, Pediatrics and International Collaboration, Health Products and Food Branch, Health Canada, Ottawa, Ontario, Canada.
Abelson J; Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Fraser B; Pharmaceutical Reviews, CADTH, Ottawa, Ontario, Canada.
Bombard Y; Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Ontario Institute of Cancer Research, Toronto, Ontario, Canada.; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health, Toronto, Ontario, Canada.
Moore Hepburn C; Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Pediatric Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
Wilson MG; McMaster Health Forum, Health Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Denburg A; Child Health Evaluative Sciences Program, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.; Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Pokaż więcej
Źródło:
Health expectations : an international journal of public participation in health care and health policy [Health Expect] 2023 Apr; Vol. 26 (2), pp. 715-727. Date of Electronic Publication: 2023 Jan 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Policy*
Technology Assessment, Biomedical*
Humans ; Adolescent ; Child ; Canada ; Costs and Cost Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Alternatives to the quality-adjusted life year: How well do they address common criticisms?
Autorzy:
Rand LZ; The Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Center for Bioethics, Harvard Medical School, Boston, Massachusetts, USA.
Melendez-Torres GJ; Peninsula Technology Assessment Group (PenTAG), Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.
Kesselheim AS; The Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Center for Bioethics, Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Health services research [Health Serv Res] 2023 Apr; Vol. 58 (2), pp. 433-444. Date of Electronic Publication: 2022 Dec 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Technology Assessment, Biomedical*
Humans ; Quality-Adjusted Life Years ; Cost-Benefit Analysis ; Australia
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Reply to: “Comments on the article entitled “Primary ADN-VPH screening in women under 30 years of age: health technology assessment”
Autorzy:
Garzón-Olivares CD; Universidad Nacional de Colombia, Bogotá (Colombia).. .
Grillo-Ardila CF; Universidad Nacional de Colombia, Bogotá (Colombia).. .
Amaya-Guío J; Universidad Nacional de Colombia, Bogotá (Colombia).. .
Pokaż więcej
Transliterated Title:
Respuesta a: “Comentarios acerca del artículo “Tamización primaria con prueba ADN-VPH en mujeres menores de 30 años: evaluación de tecnología sanitaria””
Źródło:
Revista colombiana de obstetricia y ginecologia [Rev Colomb Obstet Ginecol] 2023 Mar 30; Vol. 74 (1), pp. 92-94. Date of Electronic Publication: 2023 Mar 30.
Typ publikacji:
Letter; Comment
MeSH Terms:
Technology Assessment, Biomedical*
Papillomavirus Infections*
Humans ; Female ; Human Papillomavirus DNA Tests ; DNA
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A SWOT analysis of the development of health technology assessment in Iran.
Autorzy:
Behzadifar M; Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Ghanbari MK; Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran.
Azari S; Research Center for Emergency and Disaster Resilience, Red Crescent Society of the Islamic Republic of Iran, Tehran, Iran.; Hospital Management Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran.
Bakhtiari A; Health Equity Research Center (HERC), Tehran University of Medical Sciences, Tehran, Iran.
Rahimi S; Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Ehsanzadeh SJ; English Language Department, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Sharafkhani N; Department of Health Education and Promotion, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.
Moridi S; Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran.
Bragazzi NL; Laboratory for Industrial and Applied Mathematics (LIAM), Department of Mathematics and Statistics, York University, Toronto, Ontario, Canada.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Mar 30; Vol. 18 (3), pp. e0283663. Date of Electronic Publication: 2023 Mar 30 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Technology Assessment, Biomedical*
Health Policy*
Humans ; Iran ; Government Programs ; Communication
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The initiation, exploration, and development of hospital-based health technology assessment in China: 2005 ‒ 2022.
Autorzy:
Tang M; Shanghai Health Development Research Center, Shanghai, China.
Zhang X; Shanghai Municipal Center for Health Promotion, Shanghai, China.
Ye Z; School of Public Administration, Hainan University, Hainan, China.
Feng L; Shanghai Health Development Research Center, Shanghai, China.
Yang Y; Shanghai Health Development Research Center, Shanghai, China.
Hou Z; Shanghai Health Development Research Center, Shanghai, China.
Bai F; National Center for Medical Service Administration, National Health Commission of the People's Republic of China, Beijing, China.
Lin X; National Center for Medical Service Administration, National Health Commission of the People's Republic of China, Beijing, China.
Liu X; Shenzhen Municipal Health Commission, Shenzhen, China.
Yang H; Shanghai Sixth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Hu S; School of Public Health, Fudan University, Shanghai, China.
Song P; Center for Clinical Sciences, National Center for Global Health and Medicine of Japan, Tokyo, Japan.
He J; Shanghai Health Development Research Center, Shanghai, China.
Pokaż więcej
Źródło:
Bioscience trends [Biosci Trends] 2023 Mar 11; Vol. 17 (1), pp. 1-13. Date of Electronic Publication: 2023 Feb 12.
Typ publikacji:
Journal Article
MeSH Terms:
Technology Assessment, Biomedical*
Hospital Administration*
Hospitals, Public ; China
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Complex challenges should be approached by a multitude of theories and models.
Autorzy:
Braut GS; Research Department, Stavanger University Hospital, Stavanger, Norway.; Department of Social Science, Western Norway University of Applied Sciences, Sogndal, Norway.
Pokaż więcej
Źródło:
Risk analysis : an official publication of the Society for Risk Analysis [Risk Anal] 2023 Feb; Vol. 43 (2), pp. 236-237. Date of Electronic Publication: 2022 Nov 09.
Typ publikacji:
Journal Article
MeSH Terms:
Technology Assessment, Biomedical*
Humans ; Uncertainty
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 653

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies